S
IDXX icon

Steadtrust’s Idexx Laboratories IDXX Stock Holding History

Steadtrust’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$553K Hold
1,050
– – 0.28% 80
2026
Q1 		$590K Hold
1,050
– – 0.33% 72
2025
Q4 		$710K Hold
1,050
– – 0.44% 65
2025
Q3 		$671K Hold
1,050
– – 0.45% 59
2025
Q2 		$563K Buy
+1,050
New +$502K 0.44% 65

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Steadtrust's IDXX Position: Q2 2026 in Review

Steadtrust held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 1,050 shares worth $553K. The position accounts for 0.28% of the portfolio, ranked #80.

Steadtrust first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $710K in Q4 2025. 1,292 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Steadtrust held 1,050 shares of Idexx Laboratories worth $553K as of Q2 2026.
  • Steadtrust left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.28% of Steadtrust's portfolio in Q2 2026, its #80 holding.
  • Steadtrust first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Steadtrust's Idexx Laboratories position peaked at $710K in Q4 2025.
  • 1,292 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Steadtrust's 13F filing for Q2 2026, filed 9 Jul 2026.